Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|February 18, 2003
Inhibition of factor VIIa generation and prothrombin activation by treatment with enoxaparin in patients with unstable anginaGrigoris T Gerotziafas, Athanasios Zafiropoulos, Patrick Van Dreden, et al.
Thrombosis and Haemostasis|January 21, 2025
Influence of Direct Oral Anticoagulant Levels and Thrombin Generation on Postoperative Bleeding [SONAR]: A Nested Case-Control StudyJoseph R Shaw, Na Li, Matthieu Grussé, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|November 7, 2019
Modelization of Blood-Borne Hypercoagulability in Myeloma: A Tissue-Factor-Bearing Microparticle-Driven ProcessLoula Papageorgiou, Kutaiba Alhaj Hussen, Sandrine Thouroude, et al.
Thrombosis and Haemostasis|May 4, 2021
SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic ThrombocytopeniaIsmail Elalamy, Grigoris Gerotziafas, Sonia Alamowitch, et al.
Current Vascular Pharmacology|June 26, 2012
Effect of low molecular weight heparins and fondaparinux upon thrombin generation triggered by human pancreatic cancer cells BXPC3Grigoris T Gerotziafas, Vassiliki Galea, Elisabeth Mbemba, et al.
The Oncologist|August 15, 2018
Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer-Associated Thrombosis: The Observational ROADMAP-CAT StudyKonstantinos Syrigos, Dimitra Grapsa, Rabiatou Sangare, et al.
Thrombosis and Haemostasis|April 27, 2012
The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticlesGrigoris T Gerotziafas, Patrick Van Dreden, Mourad Chaari, et al.
Cancers|June 12, 2026
Enoxaparin, Tinzaparin, and Apixaban Modulate Cancer Cell Procoagulant Activity and Viability: Comparison with QuercetinMohammed A Baghdadi, Pedro Henrique Fernandes do Carmo Las Casas, Elisabeth Mbemba, et al.
Blood Cancer Journal|November 9, 2018
Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT studyDespina Fotiou, Theodoros N Sergentanis, Loula Papageorgiou, et al.
Blood Advances|June 11, 2026
Effect of PCC on Thrombin Generation in Patients on FXaI with Bleeding or Needing Urgent Surgery (GAUGE)Joseph R Shaw, Hannah Gray, Yan Xu, et al.
Pageof 6